Sale!

AML ETO t821 Gene Rearrangement PCR Qualitative Test

1,000 د.إ

-17%

The “AML ETO t(8;21) Gene Rearrangement PCR Qualitative Test” is a specialized diagnostic procedure aimed at detecting the presence of a specific chromosomal abnormality associated with acute myeloid leukemia (AML), known as the t(8;21) translocation. This translocation results in the ETO gene on chromosome 8 being rearranged and fused with the AML1 gene on chromosome 21, which can lead to the development of leukemia by affecting normal cell growth and differentiation.

Performed at DNA Labs UAE, this test employs the Polymerase Chain Reaction (PCR) technique, a highly sensitive method for detecting specific DNA sequences, to identify the AML ETO t(8;21) gene rearrangement qualitatively. This means the test is designed to confirm the presence or absence of the gene rearrangement, rather than quantifying the amount of rearranged gene product.

The cost of the AML ETO t(8;21) Gene Rearrangement PCR Qualitative Test is set at 1000 AED. This test is crucial for the diagnosis, prognosis, and management of patients with acute myeloid leukemia, as the presence of the t(8;21) translocation is associated with a specific subtype of AML that may respond differently to certain treatments. Identifying this genetic abnormality helps healthcare providers tailor treatment plans to improve outcomes for patients with AML.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

AML ETO t821 GENE REARRANGEMENT PCR QUALITATIVE Test

Test Cost: AED 1000.0

Introduction

The AML ETO t821 GENE REARRANGEMENT PCR QUALITATIVE Test is a diagnostic test offered by DNA Labs UAE. This test is used to detect the presence of a specific genetic rearrangement in patients with acute myeloid leukemia (AML).

Test Components

  • Price: 1000.0 AED
  • Sample Condition: 3 mL (2 mL min.) whole blood / Bone marrow from 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE.
  • Report Delivery: SampleMon / Thu by 11 am; ReportWed / Sat
  • Method: Real Time PCR
  • Test Type: Leukemia
  • Doctor: Oncologist
  • Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information

No special preparation is required before taking the AML ETO t821 GENE REARRANGEMENT PCR QUALITATIVE Test.

Test Details

The AML ETO t(821) gene rearrangement PCR qualitative test is specifically designed to detect the presence of a genetic rearrangement in AML patients. AML is a type of cancer that affects the bone marrow and blood cells.

The t(8;21) gene rearrangement is a specific chromosomal abnormality that is found in a subset of AML cases. This rearrangement involves the fusion of two genes, the AML1 gene on chromosome 21 and the ETO gene on chromosome 8.

The AML ETO t(821) gene rearrangement PCR qualitative test utilizes polymerase chain reaction (PCR) technology to amplify and detect the specific DNA sequence that indicates the presence of this gene fusion. It is a qualitative test, meaning it can determine whether the gene rearrangement is present or not, but it does not provide information about the quantity or level of the rearrangement.

This test is crucial in the diagnosis and monitoring of AML patients, as the presence of the t(8;21) gene rearrangement can influence treatment decisions and prognosis. By detecting this genetic abnormality, healthcare professionals can personalize treatment plans and predict patient outcomes more accurately.

Test Name AML ETO t821 GENE REARRANGEMENT PCR QUALITATIVE Test
Components
Price 1000.0 AED
Sample Condition 3 mL (2 mL min.) whole blood \/ Bone marrow from 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE.
Report Delivery SampleMon / Thu by 11 am; ReportWed / Sat
Method Real Time PCR
Test type Leukemia
Doctor Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information No special preparation required
Test Details

The AML ETO t(821) gene rearrangement PCR qualitative test is a diagnostic test used to detect the presence of a specific genetic rearrangement in acute myeloid leukemia (AML) patients.

AML is a type of cancer that affects the bone marrow and blood cells. The t(8;21) gene rearrangement is a specific chromosomal abnormality that is found in a subset of AML cases. This rearrangement involves the fusion of two genes, the AML1 gene on chromosome 21 and the ETO gene on chromosome 8.

The AML ETO t(821) gene rearrangement PCR qualitative test uses polymerase chain reaction (PCR) technology to amplify and detect the specific DNA sequence that is indicative of this gene fusion. It is a qualitative test, meaning it can determine whether the gene rearrangement is present or not, but it does not provide information about the quantity or level of the rearrangement.

This test is important in the diagnosis and monitoring of AML patients, as the presence of the t(8;21) gene rearrangement can impact treatment decisions and prognosis. By detecting this genetic abnormality, healthcare professionals can tailor treatment plans and predict patient outcomes more accurately.